A Combined Model Based on Bone Mineral Density for Noninvasive Prediction of Prognosis in Non‐Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors: A Multicenter Retrospective Study

Documenti analoghi

• Application of Immune Checkpoint Inhibitors in Cancer
  di: Zhijun Chen, et al.
  Pubblicazione: (2025)
• Combining JAK Inhibitors with Immune Checkpoint Inhibitors: Overcoming Resistance in Cancer Treatment
  di: Hai‐Jing Zhong
  Pubblicazione: (2025)
• Incidence of Metastasis in the Central Nervous System in Advanced Breast Cancer Treated With CDK 4/6 Inhibitors: A Multicenter, Retrospective Study
  di: Yan‐Ling Wen, et al.
  Pubblicazione: (2025)
• Incidence and Immunopathology of Myositis in Rectal Cancer Patients Treated With Neoadjuvant Immune Checkpoint Inhibitors and Chemoradiotherapy: Findings From the CHINOREC Trial
  di: Rebecca Zirnbauer, et al.
  Pubblicazione: (2025)
• Noninvasive Quantification of Hepatic Steatosis Using Ultrasound‐Derived Fat Fraction (CHESS2303): A Prospective Multicenter Study
  di: Yunlin Huang, et al.
  Pubblicazione: (2025)